Hey Resourced, yeah I think DCF models are shot in this type of market completely, one day they may come back, but shorts are running this town and fear has taken hold!!
As far as the US trials not starting yet, well I think that part is obvious, we haven't seen approval because of BSI's 180 and we know the two trials planned will cost in the order of $17m. Not hard to see why they haven't progressed.
Such is the long road of a Biotech investor!!
- Forums
- ASX - By Stock
- TIS
- bell potter target $1.20
bell potter target $1.20, page-18
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries